A Study of Systemic Chemotherapy With CPT-11 Plus HAI (FUDR+L-OHP) in Patients With Initially Unresectable CRCLM
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Oxaliplatin
Related studies linked through entity extraction aliases.
Cetuximab Plus FOLFOXIRI vs Cetuximab Plus FOLFOX For CRCLM
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
PK,PD,Safety and Tolerability of Multiple Dose Regimens of MT-3724 With Gemcitabine and Oxaliplatin for the Treatment of Patients With Relapsed/Refractory Diffuse Large B Cell Non-Hodgkin's Lymphoma
- Status
- TERMINATED
- Phase
- PHASE2
First-line Therapy in Metastatic PDAC
- Status
- UNKNOWN
- Phase
- PHASE2
A Study of Intraperitoneal Paclitaxel in Combination With SOX Compared With SOX Alone in Gastric Cancer With Malignant Ascites
- Status
- UNKNOWN
- Phase
- PHASE3
A Study of SHR-1210 in Combination With Capecitabine + Oxaliplatin or Apatinib in Treatment of Advanced Gastric Cancer
- Status
- COMPLETED
- Phase
- PHASE2
BGB A317 in Combination With Chemotherapy as First-Line Treatment in Adults With Inoperable, Locally Advanced or Metastatic Esophageal, Gastric, or Gastroesophageal Junction Carcinoma
- Status
- COMPLETED
- Phase
- PHASE2
First-line Combination of Capecitabine and Oxaliplatin Plus Bevacizumab in Elderly Patients With Metastatic Colorectal Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
Gemcitabine + Carboplatin + Nivolumab Versus Gemcitabine + Oxaliplatin + Nivolumab in Cisplatin-ineligible Patients With Metastatic Urothelial Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Neoadjuvant Capecitabine, Oxaliplatin, Docetaxel and Atezolizumab in Resectable Gastric and GE-junction Cancer (PANDA)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
SOX Versus XELOX as Adjuvant Chemotherapy for Stage III Colorectal Cancer Patients
- Status
- UNKNOWN
- Phase
- PHASE3
SLOG vs mFOLFIRINOX as the First-line Treatment in Locally Advanced Uncresectable or Metastatic Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Randomized Study to Establish the Efficacy of Oral Ice Exposure During Oxaliplatin Infusion in Preventing Oral Cold Sensitivity
- Status
- TERMINATED
- Phase
- EARLY_PHASE1
Study of Atezolizumab + FLOT vs. FLOT Alone in Patients With GC/GEJ and High Immune Responsiveness
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Ascorbic Acid and Chemotherapy for the Treatment of Relapsed or Refractory Lymphoma, CCUS, and Chronic Myelomonocytic Leukemia
- Status
- RECRUITING
- Phase
- PHASE2
An Investigational Immunotherapy Study of Nivolumab With Standard of Care Therapy vs Standard of Care Therapy for First-Line Treatment of Colorectal Cancer That Has Spread
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Phase II Randomized Trial of SLOG vs GC in Locally Advanced or Metastatic Biliary Tract Cancer
- Status
- COMPLETED
- Phase
- PHASE2
The Combination Chemotherapy of SIRIOX as First- or Second-Line Chemotherapy for Pancreatic Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
XELOX for 4 Months Versus 6 Months in Gastric Cancer (LOMAC)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
QUILT-3.070:Pancreatic Cancer Vaccine: Subjects With Pancreatic Cancer Who Have Progressed on or After Standard-of-care Therapy
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2